Twist Bioscience Corp (TWST): Next-Year EPS Estimate 33.50%
As of 2026-11-12, Twist Bioscience Corp (TWST) has a next-year EPS growth estimate of 33.50%. Featured in 5 EPS revision reports, most recently on 2026-09-25.
On 2026-11-12, analyst consensus for TWST's next-year EPS growth shifted from 38.09% to 33.50% — a negative change of 4.59 percentage points. Current-year growth is projected at 37.34%.
What's Driving This
The primary structural driver is the Oct. 13, 2026 analyst revision raising Twist Bioscience’s next-year EPS growth estimate to 38.82% from 38.15%, a modest 0.67-point increase. None of the recent headlines clearly identifies an earnings beat, contract win, guidance raise, or product launch behind that upgrade. Headlines instead point to momentum—multi-year-high trading, AI/Anthropic-related interest, and Cathie Wood’s ARKG selling TWST shares—but they do not
Generated 2026-10-22 from news as of 2026-10-22
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 33.50%
- EPS growth this year
- 37.34%
- EPS next quarter (est)
- -$0.38
- Last price
- $114.22
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 33.50% | 37.34% | -$0.38 | $114.22 |
| 2026-11-11 | 38.09% | -65.13% | -$0.39 | $122.59 |
| 2026-11-10 | 38.09% | -65.13% | -$0.39 | $132.13 |
| 2026-11-09 | 38.09% | -65.13% | -$0.39 | $135.34 |
| 2026-11-07 | 38.79% | -64.76% | -$0.38 | $120.79 |
| 2026-11-06 | 38.79% | -64.76% | -$0.38 | $120.79 |
| 2026-11-05 | 38.79% | -64.76% | -$0.38 | $120.61 |
| 2026-11-04 | 38.79% | -64.76% | -$0.38 | $142.58 |
| 2026-11-03 | 38.79% | -64.76% | -$0.38 | $140.30 |
| 2026-11-02 | 38.79% | -64.76% | -$0.38 | $129.04 |
| 2026-10-31 | 38.79% | -64.76% | -$0.38 | $152.78 |
| 2026-10-30 | 38.79% | -64.76% | -$0.38 | $152.78 |
| 2026-10-29 | 38.79% | -64.76% | -$0.38 | $173.45 |
| 2026-10-28 | 38.79% | -64.76% | -$0.38 | $173.45 |
| 2026-10-27 | 38.79% | -64.76% | -$0.38 | $159.85 |
| 2026-10-26 | 38.79% | -64.76% | -$0.38 | $145.25 |
| 2026-10-23 | 38.79% | -64.76% | -$0.38 | $139.92 |
| 2026-10-22 | 38.82% | -64.85% | -$0.38 | $135.47 |
| 2026-10-21 | 38.82% | -64.85% | -$0.38 | $149.13 |
| 2026-10-20 | 38.82% | -64.85% | -$0.38 | $142.70 |
| 2026-10-19 | 38.82% | -64.85% | -$0.38 | $139.77 |
| 2026-10-16 | 38.82% | -64.85% | -$0.38 | $132.75 |
| 2026-10-15 | 38.82% | -64.85% | -$0.38 | $144.49 |
| 2026-10-14 | 38.82% | -64.85% | -$0.38 | $148.16 |
| 2026-10-13 | 38.82% | -64.85% | -$0.38 | $151.33 |
| 2026-10-12 | 38.15% | -64.88% | -$0.39 | $151.86 |
| 2026-10-11 | 37.81% | -65.07% | -$0.39 | $159.78 |
| 2026-10-10 | 37.81% | -65.07% | -$0.39 | $159.78 |
| 2026-10-09 | 37.81% | -65.07% | -$0.39 | $159.78 |
| 2026-10-08 | 37.81% | -65.07% | -$0.39 | $152.05 |
Reports Featuring TWST
- 2026-09-25
EPS Revisions Fuel Tech Surge: P Jumps 21.2% as CBRL, TWST, MU, ON Rally
- 2026-09-24
Intel, Everpure Lead EPS Revision Rally: INTC +26%, P +17%
- 2026-09-17
$CYPH Soars 39.5% as EPS Estimate Revision Drives Healthcare Rally
- 2026-09-16
Fossil Surges 18.5% as EPS Revision Screener Flags 5 Stocks
- 2026-09-15
ATEC Leads EPS Revision Screener Winners, Jumps 18.7% to $10.66
Recent News
- FTC seeks contempt finding against Martin Shkreli for alleged pharma ban violationInvesting.com
- NeoGenomics Sinks 12% on CEO Succession Plan Despite Revenue BeatTIKR
- Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies Unloads $18M Worth Of TWST SharesStocktwits
- Cathie Woods ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This YearStocktwits
- AI Drug Discovery Forecasts Vary Widely as Sector Shifts to DeploymentPR Newswire
- What Needs To Be True To Buy Twist Bioscience Stock Now?Trefis
- Twist Bioscience Stock Jumped 16% Thursday. Leerink Says Anthropic Made It Happen.TIKR
- TWST Stock Hits Multi-Year High, But Pharma Bro Martin Shkreli Calls Twist A ShortStocktwits
- HAE, TWST Stocks Jump To Over 5-Year Highs Whats Driving The Gains Today?Stocktwits
- HAE, TWST Stocks Jump To Over 5-Year Highs Whats Driving The Gains Today?Stocktwits
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Twist Bioscience Corp's next-year EPS growth estimate?▾
As of 2026-11-12, Twist Bioscience Corp (TWST) has a next-year EPS growth estimate of 33.50%, based on analyst consensus.
When was the latest EPS estimate revision for TWST?▾
The most recent revision occurred on 2026-11-12, when analysts adjusted the next-year EPS growth estimate from 38.09% to 33.50%.
What sector and industry does Twist Bioscience Corp belong to?▾
Twist Bioscience Corp operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TWST appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Twist Bioscience Corp (TWST) appears here because it was detected by our daily top-EPS-revision-performer screen.